The Pharma Industry's Most Promising Drug Candidates

The Scientific American journal has released a list of the most promising drugs that have completed phase 1 trials. The majority of the treatments concern therapeutic areas associated with ageing such as arthritis and dementia, as well as 'diseases of civilisation' like obesity and diabetes. Cancer is also well represented, as it remains the leading killer in the West.

To read the full article, please choose one of the following options: